Early intravenous beta-blockers in patients with acute coronary syndrome-A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 915-921

  Chatterjee, Saurav ^a   Chaudhuri, Debanik ^b   Vedanthan, Rajesh ^c   Fuster, Valentin ^c,d   Ibanez, Borja ^d   Bangalore, Sripal ^e   Mukherjee, Debabrata ^f  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Beta Blocker; Cardiovascular Pharmacology; IV; Meta analysis; Mortality; Myocardial Infarction

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL; METOPROLOL; PINDOLOL; PRACTOLOL; PROPRANOLOL; TIMOLOL;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; FOLLOW UP; HEART REINFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW;

BETA- BLOCKER; CARDIOVASCULAR PHARMACOLOGY; IV; META-ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; HUMANS; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84885292166     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.050     Document Type: Article

References (33)

1. Viskin S, Barron HV. Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers? Am J Cardiol 1996;78:821-2
2. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971;43:67-82.
3. Reimer KA, Rasmussen MM, Jennings RB. Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res 1973;33: 353-63.
4. Chen ZM, PanHC, Chen YP, et al. COMMIT (ClOpidogrel andMetoprolol inMyocardial Infarction Trial) collaborative group. Early Intravenous then oral metoprolol in 45,852 subjects with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005;366:1622-32.
5. Al-Reesi A, Al-Zadjali N, Perry J, et al. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. CJEM 2008;10(3):215-23.
6. Brandler E, Paladino L, Sinert R. Does the early administration of beta-blockers improve the in-hospital mortality rate of subjects admitted with acute coronary syndrome? Acad Emerg Med 2010;17:1-10.
7. Halkin A, Grines CL, Cox DA, et al. Impact of Intravenous beta-blockade before primary angioplasty on survival in subjects undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004;43:1780-7.
8. Yusuf S, Sleight P, Rossi P, et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67(6 Pt 2):I32-41.
9. Evemy KL, Pentecost BL. Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol 1978;7:391-8.
10. Hjalmarson A, Herlitz J, Holmberg S, et al. The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67(6 Pt 2): I26-32.
11. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol 1998;32:634-40.
12. Heber ME, Rosenthal E, Thomas N, et al. Effect of labetalol on indices of myocardial necrosis in subjects with suspected acute infarction. Eur Heart J 1987;8:11-8.
13. Reduction of infarct size with the early use of timolol in acutemyocardial infarction. N Engl J Med 1984;310:9-15.
14. First International Study of Infarct Survival Collaborative Group. Randomised trial of Intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57-66.
15. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 1985;6: 199-226.
16. Norris RM, Clarke ED, Sammel NL, et al. Protective effect of propranolol in threatened myocardial infarction. Lancet 1978;2:907-9.
17. Norris RM, Sammel NL, Clarke ED, et al. Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control subjects with developing infarcts. Br Heart J 1980;43:617-22.
18. Norris RM, Barnaby PF, BrownMA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by Intravenous propranolol. Lancet 1984;2:883-6.
19. OwensbyDA,O'RourkeMF. Failure of Intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction. Aust N Z J Med 1985;15:704-11.
20. Harjai KJ, Stone GW, Boura J, et al. Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2003;91:655-60.
21. Peter T, Norris RM, Clarke ED, et al. Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation 1978;57:1091-5.
22. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in subjects with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 1991;83:422-37.
23. Van de Werf F, Janssens L, Brzostek T, et al. Short term effects of early Intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in subjects with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993;22:407-16.
24. Salathia KS, Barber JM, McIlmoyle EL, et al. Very early intervention with metoprolol in suspected acute myocardial infarction. Eur Heart J 1985;6:190-8.
25. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
26. Freemantle N, Cleland J, Young P, et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-7.
27. Faxon DP. Beta-blocker therapy and primary angioplasty: what is the controversy? J Am Coll Cardiol 2004;43:1788-90.
28. Mehta RH, Harjai KJ, Grines L. Sustained ventricular tachycardia or fibrillation in cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors and outcomes. J Am Coll Cardiol 2004;43:1765-72.
29. Ibanez B, Prat-González S, SpeidlWS, et al. Earlymetoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007;115:2909-16.
30. Ibanez B, Cimmino G, Prat-González S, et al. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol 2011;147:428-32.
31. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiacmagnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008;94:730-6.
32. Ibáñez B, Fuster V, Macaya C, et al.Modulation of the beta-adrenergic systemduring acute myocardial infarction: rationale for a new clinical trial. Rev Esp Cardiol Jul. 2011;64(Suppl. 2):28-33.
33. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and aftermyocardial infarction: an overview of the randomized trials. Prog Cardiovasc DisMar.-Apr. 1985;2(5):335-71.